Date updated:06-02-2007
FANS OF ABBOTT LABORATORIES ARE FOCUSED on the company's launch of a new drug-coated cardiac stent, which they believe could trump competitors' products and snare up to 40% of the $5 billion market. Expectations for the product have helped fuel a 50% increase in the past 18 months in shares of the Abbott Park, Ill.-based health-care concern, which closed Friday at 56.30.
But investors may be overlooking the fact that most of Abbott's profits come from its slower-growth, lower-multiple pharmaceutical division, not jazzy technologies. And some prominent doctors have started questioning the safety and efficacy of one of Abbott's best-selling drugs, TriCor, which helps patients lower triglycerides, a type of non-cholesterol fat.

-
GSK
Glaxosmithkline P - $41.47
- -0.67%
- $41.54
Concerns about fenofibrate center on creatinine, a substance produced by the muscles and eliminated by the kidneys. A rise in creatinine typically indicates some sort of kidney malfunction. Fenofibrates and other fibrate drugs have been known to result in elevated creatinine levels. A study published in March in the Journal of the American Medical Association by Dr. Steven Nissen, chairman of the department of cardiovascular medicine at the Cleveland Clinic, showed that 19 patients, or 38% in a control group that took fenofibrate, saw their creatinine levels rise above what is considered the upper limits of normal

-
MRK
Merck Co Inc - $35.33
- +0.54%
- $35.09
Nissen also raised concerns about Vioxx as well

-
ABI
Safety First Trus - $11.20
- -3.45%
- $11.53
Barrons feels that the stock is pricey at 56- especially as questions about TriCor seem destined to grow

-
AMGN
Amgen Inc. - $56.06
- -0.14%
- $56.05
No Analysis added

-
DNA
N/a - $80.43
- 0.00
- $80.43
No Analysis added

-
ABT
Abbott Laboratori - $52.96
- -0.41%
- $52.89
No Analysis added
- Top Professional Portfolios
- 1. Fidelity Contrafund - ...
- 2. Navellier & Associ...
- 3. Calamos Advisors
- 4. Argus Management
- 5. Bernard L. Madoff Inve...
- show all
- Top Do-It-Yourself Portfolios
- » Joseph Russell Portfolio 1
- » Albo's First Portfolio
- » Darrell Werth Portfolio 1
- » Echo5Joker's Portfolio
- » jgroov Portfolio 1
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
Not a Stockpickr member? Join the community today -- for free.Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about...
By Roberto Pedone Posted on Nov. 20, 2009 According to Jim Cramer, options expiration is driving the current market selloff. He pointed out that the only stocks that we...
By Roberto Pedone Posted on Nov. 19, 2009 According to CNBC’s “Fast Money” traders, the stock market is showing no signs of stopping its current bull run. Joe Ter...
By Jonas Elmerraji Posted on Nov. 18, 2009 There are plenty of reasons for stocks to have the attention of short-sellers. Waning financials, a deteriorating business mo...
A. Long term investment considerations: 20%
in OIH ETF; 10% in GDX ETF and 10% in
GDXJ (Van Eck Jr Gold Mining) ETF . . .
If your grandparents were thoughtful
enough to provide you with funds to
become actively involved in the
trading/investing world, communicate
with them on a regular basis in order to
compare their point of view/insight with
other reliable sources . . . including
those reflected on Online School @
http://www.onlineschools.org/2009/10/22/
100-best-blogs-for-future-investors/
and ValueWiki @
http://blog.valuewiki.com/2007/02/26/top
-100-finance-blogs/
Be open/flexible, resourceful, and
pursue due diligence (research). Best of
luck.
A. The only one I own : SLX,
too hard pick a winner out all of them
Here are some of the biggest stocks that made the 52-week high list on Nov. 20, 2009. more
Unusually active options can often indicate that a major event in a stock is about to take place, or that unsophisticated investors (using options in lieu of leverage) are ... more
These are some of the stocks mentioned on TheStreet.com TV recently. Click the URL below each stock to watch the videos. more











Comments not available